Nyu langone medical center, Medical center in New York City, New York

New York, March 26 An orally absorbed tablet containing cannabidiol (CBD) effectively reduces pain after shoulder surgery with no safety concerns, a new study finds.The study found that the tablet ORAVEXXTM safely managed pain after minimally invasive rotator cuff surgery, and did not produce side effects sometimes associated with CBD use, such as nausea, anxiety, and liver toxicity."There is an urgent need for viable alternatives for pain management, and our study presents this form of CBD as a promising tool after arthroscopic rotator cuff repair," lead investigator Michael J. Alaia from NYU Langone Health."It could be a new, inexpensive approach for delivering pain relief, and without the side effects of anti-inflammatory drugs like NSAIDs and addiction risks linked to opiates. Additionally, CBD has the benefit of pain relief without the psychotropic effects associated with THC or marijuana," Alaia added.For the study, presented at the American Academy of Orthopaedic Surgeon's (AAOS) 2022 Annual Meeting in Chicago, the multi-centre Phase 1/2 clinical trial randomly sorted 99 participants across two study sites between the ages of 18 and 75 into a placebo group and a group receiving oral-absorbed CBD.Participants were prescribed a low dose of Percocet, instructed to wean off the narcotic as soon as possible and to take the placebo/CBD three times a day for 14 days after the surgery.On the first day after surgery, patients receiving CBD experienced on average 23 per cent less pain as measured by the Visual Analog Scale (VAS) pain score compared to patients receiving the placebo, highlighting that in patients with moderate pain, CBD may render a significant benefit.On both the first and second days after surgery, patients receiving CBD reported 22 to 25 per cent greater satisfaction with pain control compared to those receiving placebo.Further analysis also showed that patients receiving 50 mg of CBD reported lower pain and higher satisfaction with pain control compared to patients receiving placebo. No major side effects were reported.Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Nyu Langone Medical CenterFOLLOW

Nyu langone medical center, Latest News

Washington [US], April 24 : A new study claimed certain stem cells have a unique ability to move between ... ...

Experiments on mice and human cells reveal that the number of specialised immune cells ready to combat skin cancer ... ...

The Russian consulate in New York City was vandalized with red spray paint early Friday in a possible bias ... ...

New York, June 25 Exposure to above-average levels of outdoor air pollution increased the risk of death by ... ...

Initial study results prove that an experimental drug called 'nemvaleukin alfa' can be used to treat several types of late-stage cancer in some patients when used alone or in combination with another anticancer drug 'pembrolizumab.' ...

Mumbai, May 17 As it was Bollywood heartthrob Vicky Kaushal's birthday, his ladylove and actress Katrina Kaif shared ... ...

Several people were shot at in a subway station in New York's Brooklyn, local media reported. People tweeted photos ... ...

New York, March 26 An orally absorbed tablet containing cannabidiol (CBD) effectively reduces pain after shoulder surgery with ... ...